威尔药业 (603351.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(威尔药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 329,832,361.621,155,839,777.59828,679,872.71522,970,497.42246,445,272.151,111,010,682.20850,975,692.57588,110,281.95290,586,279.28
 营业利润(元) 40,841,033.43121,776,527.3283,948,045.0856,599,674.0431,637,464.96113,229,667.4988,142,528.7769,222,656.4532,090,021.69
 利润总额(元) 40,829,351.98121,441,235.5183,796,714.0356,468,720.1731,600,745.92112,850,708.3488,024,122.7369,140,199.1332,044,469.08
 净利润(元) 33,516,432.21109,114,562.2175,979,850.0251,970,665.1525,635,740.8494,432,099.3777,248,178.3259,806,504.0826,763,211.11
 归属于母公司股东的净利润(元) 34,603,545.42112,199,192.8778,271,460.3953,386,352.5026,310,732.1995,028,722.3278,551,568.9060,762,416.7627,529,731.11
盈利能力:
 销售毛利率(%) 26.0227.4127.2428.2930.2627.2829.3430.4929.54
 销售净利率(%) 10.169.449.179.9410.408.509.0810.179.21
 净资产收益率(%) 2.217.325.203.651.79----
 总资产报酬率ROA(%) 1.926.144.302.961.70----
 投入资本回报率ROIC(%) 1.685.693.952.741.365.494.613.671.70
营运能力:
 存货周转率(次) 1.305.003.672.150.99----
 应收账款周转率(次) 1.846.825.083.411.75----
 总资产周转率(次) 0.150.520.380.250.12----
偿债能力:
 资产负债率(%) 28.8730.1131.9631.7931.5930.6729.7330.0827.00
 股东权益比率(%) 70.8269.5367.6467.8368.0169.2370.2069.8472.90
 已获利息倍数(倍) 18.089.559.209.579.2212.9115.8117.2614.25
 流动比率 1.171.071.010.860.870.810.830.901.01
 速动比率 0.770.740.710.540.530.500.430.560.63
发展能力:
 营业收入增长率(%) 33.844.04-2.62-11.08-15.196.5911.3621.3127.77
 营业利润增长率(%) 29.097.55-4.76-18.24-1.41-5.45-21.86-9.15-7.78
 税后利润增长率(%) 31.5218.07-0.36-12.14-4.43-6.26-6.317.555.04
 净资产增长率(%) 7.237.036.156.276.387.068.107.697.11
 总资产增长率(%) 2.986.5810.169.4214.0416.1114.6820.6815.11

前瞻产业研究院